Paradigm Biopharmaceuticals Limited.. Stock: price and insider trades · Australia
Paradigm Biopharmaceuticals Limited..: what insiders have been doing
Paradigm Biopharmaceuticals Limited. is a listed company. Its insiders report their share dealings to ASX. Over the twelve months to 18 October 2026, 7 filings were filed, from 3 insiders.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
With 7 filings in twelve months, the company is more active than the median of 4 filings across the 1,605 companies we follow on the same exchange.
Insider buying of Paradigm Biopharmaceuticals Limited. has been absent for the past year.
Every figure here comes from the filings published by ASX and describes the past, not future prices; it is not investment advice.
Financial data
as of FY 2026FY ended June 2026 · cache
- ●Executives0ASX
- ●Executives0 AUD0ASX
- ●Executives1 AUD0ASX
- ●Executives30,000 AUD0ASX
- ●Executives90,000 AUD0ASX
- ●Executives0ASX
- ●Executives0ASX
7 of 7 declarations
About Paradigm Biopharmaceuticals Limited..
PARADIGM BIOPHARMACEUTICALS LIMITED is an Australian Securities Exchange listed company focused on developing treatments for chronic diseases and musculoskeletal disorders. It specializes in regenerative medicine and stem cell-based therapies.